Injective INJ
Current Price
$4.54 -0.69%
$0.0800 Daily Range (1.76%)
$4.52$4.60
$26.79M Daily Volume
300 BTC
Vol/MktCap: 5.91%
Market Performance
0.16% Relative BTC Volume
The total volume of Injective is $26.79M over the past 24 hours, compared to $16.24B total Bitcoin volume.
Hourly Moving Average
8 SMA $4.56 -0.38%
13 SMA $4.56 -0.46%
21 SMA $4.56 -0.55%
55 SMA $4.59 -1.04%
144 SMA $4.66 -2.57%
Price Performance
-0.11% 1 Hour Change
$4.54 from $4.55
-14.32% 7 Day Change
-$0.6503 from $5.19
-12.28% 14 Day Change
-$0.5576 from $5.10
+0.32% 30 Day Change
$0.0144 from $4.53
All Time High
March 14, 2024
$52.62 -91.37%
-$48.08 vs. now
24H Change
-3.40M USD -0.75%
-38 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ Available100.00% circulating A lower circulating supply may increase over time, reducing scarcity and potentially causing a drop in price. A higher circulating supply is less susceptible to dilution, offering the potential for a more stable price long-term.
Relative Supply Ratio
5.00 x BTC Supply5:1 supply ratio
RSR reflects potential differences in tokenomics, such as inflation rates, utility, or burn mechanisms, which can impact long-term value and scarcity.
Relative Trade Volume
5.88M INJ
traded over past 24 hours
5.88% of circulating supply
A higher trade volume relative to market cap indicates strong market activity and liquidity, while a lower ratio may suggest reduced interest, lower liquidity, or potential price stagnation.
Conversion Tool
Injective AI Market Analysis
Injective (INJ) is currently priced at $4.53, showing a slight decline of 0.79% over the past 24 hours. The daily trading range has been narrow, with a high of $4.60 and a low of $4.52, indicating limited volatility and a cautious market sentiment.
The trading volume stands at approximately $27.2 million, which corresponds to 6.01% of its market cap, suggesting moderate investor interest. However, the price action reflects a bearish trend, as indicated by the moving averages; all short-term SMAs (8, 13, 21, and 55) are trending downward, with the 144 SMA showing a more significant decline of 2.78%.
The Relative Strength Index (RSI) metrics reveal an oversold condition, particularly in the 1-hour timeframe where it stands at 36. The 7-day RSI at 42 indicates a weak momentum, further corroborated by the significant price drops over the past week (-15.58%) and two weeks (-13.67%).
In the context of the all-time high of $52.62 reached on March 14, 2024, the current price shows a drastic decline, emphasizing the bearish sentiment prevailing in the market. Despite a slight recovery from lower levels in the past month, the overall trend remains downward, with a 30-day price change of -2.45%.
Given the current technical indicators and the bearish momentum reflected in both the moving averages and RSI metrics, Injective appears to be under pressure. The combination of declining prices, low trading volume relative to market cap, and weak momentum signals suggests that further declines may be imminent.
Rating: Sell. The ongoing bearish trend and poor momentum indicators indicate that INJ may continue to face downward pressure in the near term. Investors should consider exiting positions to minimize potential losses.
The trading volume stands at approximately $27.2 million, which corresponds to 6.01% of its market cap, suggesting moderate investor interest. However, the price action reflects a bearish trend, as indicated by the moving averages; all short-term SMAs (8, 13, 21, and 55) are trending downward, with the 144 SMA showing a more significant decline of 2.78%.
The Relative Strength Index (RSI) metrics reveal an oversold condition, particularly in the 1-hour timeframe where it stands at 36. The 7-day RSI at 42 indicates a weak momentum, further corroborated by the significant price drops over the past week (-15.58%) and two weeks (-13.67%).
In the context of the all-time high of $52.62 reached on March 14, 2024, the current price shows a drastic decline, emphasizing the bearish sentiment prevailing in the market. Despite a slight recovery from lower levels in the past month, the overall trend remains downward, with a 30-day price change of -2.45%.
Given the current technical indicators and the bearish momentum reflected in both the moving averages and RSI metrics, Injective appears to be under pressure. The combination of declining prices, low trading volume relative to market cap, and weak momentum signals suggests that further declines may be imminent.
Rating: Sell. The ongoing bearish trend and poor momentum indicators indicate that INJ may continue to face downward pressure in the near term. Investors should consider exiting positions to minimize potential losses.
Updated 144 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
You May Also Like
In The News

Chainlink (LINK) Stuck In A Box: What The Current Price Channel Means For Traders
Chainlink’s native token, LINK, continues to trade within a clearly defined price channel, reflecting a period of consolidation as the broader crypto market is yet to establish a…

Silver Breaks $100, but Selling Physical Metal Isn’t as Simple as It Sounds
This weekend, with silver changing hands at $103 an ounce, an X account known as Stoic Trader said he was “sitting on 1,000 ounces of silver bars” and claimed he has been…

‘Time to go full PQ’ – Ethereum Foundation launches post-quantum push
Will EF's quantum push trigger ETH/BTC ratio to explode by 200%?

Ethereum Foundation forms expert group to address quantum computing threats
The Ethereum Foundation has elevated post-quantum cryptography to a top priority and formed a dedicated PQ team.